Business · 30/05/2025Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Two New Drug Applications from Meda AB and B. Braun Medical, Inc.
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of two new drug applications (NDAs) from Meda AB and B. Braun Medical, Inc. following notification from the applicants that the drug products are no longer marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →